Researchers at The Hospital for Sick Children (SickKids) in Toronto published a study in Nature on May 13, 2026 identifying PTCHD1-AS, a non-coding RNA gene on the X chromosome, as specifically linked to autism's core social and repetitive behavioral traits without affecting cognition. The team analyzed genomic data from over 9,300 individuals with autism and 8,332 controls, then validated the findings in mouse models that displayed social deficits and repetitive behaviors without learning impairments or ADHD-like symptoms.

This is the first time a non-coding RNA gene has been definitively tied to autism's hallmark behavioral traits specifically, rather than broader developmental outcomes. SickKids Chief of Research Steve Scherer said the findings could lead to precision therapeutics for all autism diagnoses.

What Makes This Discovery Different

Most autism-related genes identified to date are protein-coding genes associated with a range of developmental outcomes, including intellectual disability and ADHD. PTCHD1-AS is different. It's a long non-coding RNA, a type of genetic material that doesn't produce proteins but regulates other genes, and its deletion or disruption produces a specific behavioral profile.

The research team, led by first author Lisa Bradley and senior author Stephen W. Scherer, identified 27 males with autism who had X-chromosome microdeletions affecting PTCHD1-AS. In mouse models engineered to lack this gene, male mice showed increased repetitive behaviors, impaired social communication, and difficulties with social interaction without cognitive deficits or hyperactivity.

Bradley noted that "there is a different biology involved with our PTCHD1-AS model compared to other ASD protein-coding models." The study found that disruption of PTCHD1-AS affects oligodendrocytes, astrocytes, and neurons in the striatum, a brain region involved in movement and reward processing, impacting myelination and synaptic plasticity. These changes led to reductions in conventional protein kinase C (cPKC) isoforms and enhanced striatal synaptic plasticity.

Why Males Are More Often Diagnosed

PTCHD1-AS is located on the X chromosome. Males have one X chromosome, while females have two. If a male inherits a deletion or disruption affecting PTCHD1-AS, he has no backup copy. Females with one affected copy may be protected by the second, unaffected X chromosome.

The study found that deletions involving PTCHD1-AS increased the odds of autism in males by 2.56 times (P = 0.01). This provides genetic evidence for what clinicians have observed for decades: autism is diagnosed more frequently in boys than girls, with current estimates suggesting a 4:1 ratio.

Understanding the X-linked genetic contributions to autism may also explain why girls with autism often present differently and why many remain undiagnosed or diagnosed later.

What This Means for Precision Medicine

The discovery of PTCHD1-AS as a gene specifically tied to social and repetitive behaviors opens a pathway for targeted therapies. Scherer told media outlets that the findings "could lead to precision therapeutics for all autism diagnoses."

Precision medicine in autism means developing treatments that address specific genetic or biological mechanisms rather than applying one-size-fits-all interventions. If a child's autism is linked to PTCHD1-AS disruption, future therapies could target the downstream effects, such as myelination changes or synaptic plasticity alterations, rather than attempting to address all autism symptoms broadly.

This approach is already used in other conditions. Genetic testing for developmental delays has become standard practice in pediatrics because it identifies specific diagnoses that inform treatment. The American Academy of Pediatrics updated its guidelines in 2023 to recommend chromosomal microarray testing and, in some cases, whole-genome sequencing for children with unexplained developmental delays or intellectual disabilities.

The SickKids study used whole-genome sequencing, which captures both coding and non-coding regions. Most clinical genetic testing panels focus on protein-coding genes and would miss PTCHD1-AS deletions. As research identifies more non-coding RNA genes involved in autism, testing protocols will need to expand.

What Families Can Do Now

If your child has an autism diagnosis, you can take these steps:

• Ask your care team about genetic testing. Specifically, ask whether your child has had chromosomal microarray testing or whole-genome sequencing. If not, ask whether it's recommended based on your child's profile. Understanding genetic testing options can help you decide what makes sense for your family.
• Request a copy of any previous genetic test results. You have the right to your child's medical records, including genetic test reports. If testing was done years ago, ask whether newer testing methods would provide additional information.
• Stay informed about clinical trials. As researchers develop therapies targeting PTCHD1-AS or related pathways, clinical trials will follow. ClinicalTrials.gov allows you to set up alerts for specific conditions and interventions.
• Don't wait for a genetic answer to start interventions. Genetic discoveries like this one take years to move from the lab to clinical practice. Evidence-based therapies such as behavioral interventions, speech therapy, and occupational therapy work regardless of genetic profile.

The Bigger Picture

Non-coding RNA genes make up a significant portion of the human genome but have been understudied compared to protein-coding genes. The SickKids team's work demonstrates that these genes play critical roles in brain development and behavior.

The study also highlights the value of large-scale genomic databases. The researchers analyzed data from thousands of individuals, which allowed them to identify rare deletions that wouldn't be visible in smaller samples. As more families participate in research studies that collect genetic data, the field's ability to identify these patterns improves.

Navigating a rare disorder diagnosis often involves genetic testing as a first step. The same is increasingly true for autism, particularly when families want to understand whether there's a hereditary component or whether future children might be affected.

Where to Find More Information

The full Nature article is available at nature.com/articles/s41586-026-10515-6. The University of Toronto's Temerty Faculty of Medicine published a detailed summary of the research for general audiences.

If you're considering genetic testing, start by asking your child's pediatrician or developmental specialist for a referral to a genetics clinic or genetic counselor. They can review your child's history and recommend appropriate testing based on current guidelines.